MedTrace Logo

Efficacy and Safety of Prehospital Administration of Bivalirudin in STEMI Patients

NCT00391326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2008-05-21

No results posted yet for this study

Summary

The purpose of this study is to describe the efficacy and safety of prehospital administration of bivalirudin, as a substitute for heparin, in patients with acute myocardial infarction redirected for primary angioplasty bypassing local hospitals, immediately after the diagnosis is confirmed via tele-transmission of a 12-lead electrocardiogram.

Conditions

  • Acute Myocardial Infarction

Sponsors & Collaborators

  • H:S Laegeambulance

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Peter Clemmsensen, MD. phD · Rigshospitalet, Denmark

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00391326 on ClinicalTrials.gov